| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.033 | 0.5 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |